Cognition Therapeutics, Inc. (CGTX)
0.6988
-0.01
(-1.52%)
USD |
NASDAQ |
Nov 03, 16:00
0.6988
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Max Drawdown (5Y) : 98.16% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 98.16% |
| September 30, 2026 | 98.16% |
| August 31, 2026 | 98.16% |
| July 31, 2026 | 98.16% |
| June 30, 2026 | 98.16% |
| May 31, 2026 | 98.16% |
| Date | Value |
|---|---|
| April 30, 2026 | 98.16% |
| March 31, 2026 | 98.16% |
| February 28, 2026 | 98.16% |
| January 31, 2026 | 98.16% |
| December 31, 2025 | 98.16% |
| November 30, 2025 | 98.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Bristol Myers Squibb Co. | 47.67% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
| Johnson & Johnson | 18.44% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -62.43 |
| Beta (5Y) | 1.840 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 152.9% |
| Historical Sharpe Ratio (5Y) | -0.3094 |
| Historical Sortino (5Y) | -0.9636 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 40.06% |